Remove Electrophysiology Remove General Cardiology Remove Heart Failure
article thumbnail

Top Cardiology Conferences in 2024

Cardiology Update

Important Deadlines: 12 Feb ruary 2024 : Late-breaking science submissions 27 Feb ruary 2024 : Early Registration Savings 26 Mar 2024 : Late registration savings Fees: Visit the ESC Preventive Cardiology 2024 website for registration options. Hashtag: #ESCPrev2024 5. Hashtag: #HeartFailure2024 6.

article thumbnail

ESC 2024 Highlights

Cardiology Update

Chadi Alraies discusses some of the important trials presented at the European Society of Cardiology 2024 congress. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The post ESC 2024 Highlights appeared first on Cardiology Update.

Research 130
article thumbnail

Ebstein’s Anomaly of Tricuspid Valve

All About Cardiovascular System and Disorders

Electrophysiological study will show that, and this pathway can be ablated. Ebstein’s anomaly may present with a murmur for evaluation in the pediatric age group or in adults with arrhythmias or heart failure with cyanosis and exercise intolerance.

article thumbnail

Rate vs Rhythm Control in Atrial Fibrillation

All About Cardiovascular System and Disorders

AF-CHF trial in those with AF and congestive heart failure also failed to show any advantage for the rhythm control strategy [3]. Overall, it appears that rhythm control strategy in AF may be better in those with heart failure and in those with associated cardiovascular conditions and early AF.

article thumbnail

ACC 2024 Highlights

Cardiology Update

Chadi Alraies discusses the top impactful trials presented at the 2024 American College of Cardiology conference. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The post ACC 2024 Highlights appeared first on Cardiology Update.

article thumbnail

AHA 2023 Highlights

Cardiology Update

Chadi Alraies discusses highlights from the American Heart Association (AHA) Scientific Sessions 2023, which were held in Philadelphia, Pennsylvania (PA), on November 11-13, 2023. There were many important developments in presented in key clinical trial presentations and publications stemming from the AHA Scientific Sessions 2023.

article thumbnail

Highlights of ACC 2024

Cardiology Update

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI).

Angina 52